1167 — Jacobio Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- HK$3.91bn
- HK$2.13bn
- CNY53.53m
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan
Brief: Jacobio Pharmaceuticals To Repurchase Up To 78.37 Million Shares, 10% Of Issued Shares
Brief: Jacobio Pharmaceuticals Says Co Receives $100 Million Upfront Payment For Jab-23E73
CEO
Brief: Jacobio Pharma Announces Strategic Partnership With Oceanpine Capital
Brief: Jacobio Pharmaceuticals Says Oceanpine Capital To Buy 80% Jacoray Pharmaceutical Technology
Brief: Jacobio Pharmaceuticals Says Parties Acting In Concert Of Co Purchase 402,000 Shares
Brief: Jacobio Pharmaceuticals Group Purchases 60,900 Shares At HK$7.16 Per Share From July 24-29
Brief: Jacobio Pharmaceuticals Says Concert Parties Purchase 240,000 Shares
Brief: Jacobio Pharmaceuticals Announces Parties Acting In Concert Of Co Buy 854,400 Shares At HK$5.88 Each
State-owned Chinese carmakers GAC and JAC forecast record Q2 losses
Brief: Jacobio Pharmaceuticals Group Co To Repurchase Up To 78.9 Million Shares
Brief: Jacobio Pharmaceuticals Posts FY Revenue RMB 155.7 Million
Brief: Jacobio Pharmaceuticals Says Glecirasib Granted Orphan Drug Designation In Europe
Brief: Jacobio Pharmaceuticals Got Investigational New Drug Approval From U.S. FDA
Brief: Jacobio Pharmaceuticals Says Intention To Conduct On-Market Share Repurchase